Condition: Hyperlipidemia · Medication Nonadherence · Sponsor: National University of Singapore
Investigators hypothesize that the use of a human coach-supported digital/AI personal health assistant (app) will improve adherence to cholesterol-lowering medications (statins with or without ezetimibe) among patients with hyperlipidaemia and suboptimal LDL-C control, when compared to standard care.
This description comes directly from the study's public registry record.
Doreen Su-Yin Tan, Pharm.D. · 66016471 · doreen.tan.sy@nus.edu.sg
Always discuss trial participation with your own doctor first.
| National Healthcare Group Polyclinics | Singapore, Singapore | Recruiting |
| National University Polyclinics | Singapore, Singapore | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06614049